Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patient blood management in stem cell transplant

Jambhekar N et al. AABB 2018, Abstract PBM3-ST4-22

Publish date:: November 28, 2018

Key clinical point: A patient blood management program in a hematopoietic stem cell transfusion program reduced inappropriate transfusions and costs.

Major finding: The program saved more than $600,000 in transfusion-related costs.

Study details: Retrospective study that compared clinical outcomes for 728 patients before and after implementation of a PBM program.

Disclosures: The study was internally funded. Dr. Jambhekar reported having no financial disclosures.

Read the article here.

Citation:

Jambhekar N et al. AABB 2018, Abstract PBM3-ST4-22.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Transfusion Medicine

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

INR fails to predict bleeding in patients with cirrhosis,

Study finds no link between platelet count, surgery bleed risk in cirrhosis,

Global Blood Supply Runs Low,

Best practice alerts really can work,